Reuters - Before the Bell

Click to View in Browser

Tuesday, October 31, 2017

Under Armour slashes 2017 forecast, revenue falls

(Reuters) - Under Armour Inc slashed 2017 sales and profit forecasts and reported its first year-on-year fall in revenue in the third quarter as it took an $85 million charge for restructuring and faced fierce competition from Nike and Adidas .

ADM profit misses estimates on weaker margins

(Reuters) - U.S. agricultural trader Archer Daniels Midland Co on Tuesday reported a smaller-than-expected quarterly profit, hurt by poor margins in its agriservices and oilseeds businesses.

Pfizer's quarterly profit beats estimates

(Reuters) - Pfizer Inc reported a bigger-than-expected quarterly profit, benefiting from strong demand for its newer drugs.

Futures higher with earnings, Fed in focus

(Reuters) - U.S. stock index futures were slightly higher on Tuesday following a fresh set of earnings reports, while investors waited for an announcement on the new Federal Reserve head.

Airbus's legal troubles grow as admits inaccurate U.S. arms filings

PARIS (Reuters) - Airbus said on Tuesday it had uncovered inaccuracies in its filings to U.S. regulators over arms technology sales, drawing the United States for the first time into a scandal over alleged misconduct at Europe's largest aerospace firm.

Clariant CEO calls independent review 'premature' amid shareholder row

ZURICH (Reuters) - Clariant Chief Executive Hariolf Kottmann said it would be "premature" to do an outside strategy review, a key demand of activist shareholders who derailed the Swiss chemical maker's planned $20 billion merger with U.S.-based Huntsman .

Exclusive: Swiss prosecutors seek widening of secrecy law to bankers abroad

ZURICH/LONDON (Reuters) - Swiss prosecutors are seeking a court ruling that would make it easier to convict whistleblowers for breaking the country's bank secrecy law wherever they are in the world, legal documents show.

U.S. business group worries Trump unprepared for commercial talks with China

BEIJING (Reuters) - A top U.S. business lobby in China said on Tuesday it was concerned U.S. President Donald Trump's administration was not making sufficient preparation for talks on imbalances in the bilateral economic relationship ahead of his November visit.

European stocks at five-and-a-half-month high ahead of growth data

LONDON (Reuters) - European shares were at a 5 1/2-month high and Italian bonds were set for their best month in over two years on Thursday, before the release of data expected to underscore the robust improvement in the euro zone's economy.

Japan's Kirin cashes out of Amgen drug joint venture

TOKYO (Reuters) - Japan's Kirin Holdings Co Ltd said on Tuesday it would sell its share in a pharmaceutical research joint venture with California-based drugmaker Amgen Inc for $780 million.